Platelets are thought of as a type of blood cell, but they're really small pieces of a cell. They start as a large cell in the bone marrow called the megakaryocyte. Pieces of this cell break off and enter your bloodstream as platelets, which you need for your blood to clot. Platelets plug up damaged areas of blood vessels caused by cuts or bruises. If you have a shortage of platelets (a condition called thrombocytopenia) you can bleed and bruise a lot.
Features of chronic myelomonocytic leukemia
People with CMML may have shortages of some blood cells, but a main problem is too many monocytes. (at least 1,000 per mm 3 ). Often, the monocyte count is much higher, causing their total white blood cell count to become very high as well. Since CMML has features of both a myelodysplastic syndrome 8 and myeloproliferative neoplasm, experts created a new category for it: myelodysplastic/myeloproliferative neoplasm (myelo --bone marrow, proliferative --excessive growth, dysplastic --abnormal looking).CMML is the most common disease in this group. Much less common diseases in this group are atypical chronic myeloid leukemiaand juvenile myelomonocytic leukemia. All of these diseases produce a lot of abnormal blood cells.
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What Are the Key Statistics About Chronic Myelomonocytic Leukemia?
Chronic myelomonocytic leukemia (CMML) is rare, only occurring in 4 of every million people in the United States each year. That works out to about 1,100 cases each year. This disease is rare in young people. Almost 9 of 10 of cases are diagnosed in people 60 and older. CMML occurs more often in men than in women.
Visit the American Cancer Society's Cancer Statistics Center 1 for more key statistics.
Hyperlinks
Last Medical Review: October 17, 2017 Last Revised: October 25, 2017
What's New in Chronic Myelomonocytic Leukemia Research and Treatment? Genetics
Research on the causes 1 , diagnosis 2 , andtreatment 3 of chronic myelomonocytic leukemia (CMML) is being done at many cancer research centers. Scientists are making progress in understanding which changes in a person's DNA and RNA can cause normal bone marrow cells to develop into leukemia cells.
Studies have found that changes in the structure or activity of certain genes 4 in CMML cells may help predict patients' outcomes and how likely they are to go on to develop acute leukemia. Research continues in this area, and someday, this information may help guide treatment decisions.
As more information from this research unfolds, it may be used in designing new drugs or developing gene therapy. This approach replaces the abnormal DNA of cancer cells with normal DNA to restore normal control of cell growth.
Chemotherapy
Studies are in progress to find the best combination of chemotherapy drugs while trying to limit side effects. New drugs are continually being developed and tested.
As researchers have learned more about what makes cancer cells different from normal
American Cancer Society cancer.org | 1.800.227.2345 ____________________________________________________________________________________ cells, they've begun to develop drugs that target these differences. Studies are looking at targeted therapies 5 to treat CMML. These therapies target things like specific cell signaling pathways to shut down cancer cell growth. Some of these drugs are already being used to treat other cancers.
Stem cell transplant
Scientists continue to refine this procedure so that it works better and causes fewer problems. They are also looking at which patients will benefit the most and hownewer transplant methods 6 might be used to treat CMML. 
Prevention
There is no way to prevent most cases of CMML. Rarely, CMML is caused by chemotherapy and radiation treatments for other cancers. Doctors are studying ways to minimize the risk for patients receiving these treatments by avoiding the chemotherapy drugs that are more likely to lead to CMML.
What Are the Risk Factors for Chronic Myelomonocytic Leukemia?
A risk factor is anything that changes your chance of getting a disease such as cancer. Different cancers have different risk factors. For example, exposing skin to strong sunlight is a risk factor for skin cancer. Smoking is a risk factor for lung cancer and many other cancers. But people without any risk factors can still get the disease. And having a risk factor, or even several, does not mean that you will get the disease. Because chronic myelomonocytic leukemia (CMML) is rare, it has been hard to study. For a long time it was grouped with myelodysplastic syndrome 1 s. As a result, only a few risk factors are known for this disease.
Age
The risk of CMML increases with age. This disease is rare in those younger than 40, with most cases found in people 60 and older.
Sex
CMML is about twice as common in men as in women.
Cancer treatment
Prior treatment with chemotherapy 2 seems to increase the risk of CMML. Since most cases of chronic myelomonocytic leukemia (CMML) have no known cause, this disease can rarely be prevented.
Treating cancer with chemotherapy and radiation may cause CMML. Doctors are studying ways to minimize the risk of CMML developing in patients receiving these treatments. In some cancers, doctors may try to avoid using the chemotherapy drugs that are more likely to lead to CMML. For certain cancers, however, these drugs may be needed. Often, the obvious benefits of treating life-threatening cancers with chemotherapy and radiation therapy must be balanced against the small chance of developing CMML several years later. 
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Detection and Diagnosis
Catching cancer early often allows for more treatment options. Some early cancers may have signs and symptoms that can be noticed, but that is not always the case. 
Signs and Symptoms of Chronic Myelomonocytic Leukemia
The most common sign of chronic myelomonocytic leukemia (CMML) is having too many monocytes (seen on a blood test).
Having too many monocytes also causes many of the symptoms of CMML. These monocytes can settle in the spleen or liver, enlarging these organs. An enlarged spleen (called splenomegaly) can cause pain in the upper left part of the belly (abdomen). It can also cause people to notice they feel full too fast when they eat. If the liver gets too big (called hepatomegaly), it causes discomfort in the upper right part of the abdomen. 
How Is Chronic Myelomonocytic Leukemia Diagnosed?
If signs and symptoms suggest you may have chronic myelomonocytic leukemia (CMML), the doctors will look at cells from your blood and bone marrow to confirm this diagnosis.
Blood tests
The complete blood count 1 (CBC) measures different cells in the blood, such as the red blood cells, the white blood cells, and the platelets. The CBC is often done with a differential count (or "diff"), which is a count of the different types of white blood cells in the blood sample. In a blood smear, some of the blood is put on a slide to see how the cells look under the microscope.
People with CMML have higher numbers of monocytes, (at least 1,000 per mm 3 ).
Sometimes they have low numbers of other white blood cells. They may have shortages of red blood cells and blood platelets, as well.
Some patients have a small number of monoblasts in the blood. Monoblasts are the early, immature cells that grow and divide to make mature monocytes. Normally, these cells are only found in the bone marrow. It's never normal to see blasts in the blood, and it's often a sign of a bone marrow problem.
Blood cells from CMML patients may also have certain changes in size, shape, or other features that can be seen under the microscope. Blood abnormalities may suggest CMML, but an exact diagnosis cannot be made without looking at and testing cells taken from the bone marrow.
Other blood tests may be done to check for other possible causes of low blood counts, such as low levels of vitamin B12 and folate. Tests may also be done to look for other causes of a high white blood cell count, such as an infection.
Bone marrow tests
Samples of your bone marrow are taken by bone marrow aspiration and biopsy for testing. The samples are usually taken from the back of the pelvic (hip) bone. These tests are used to diagnosis and classify the type of blood cancer you have. They may be repeated later to see if treatment is working or to see if the CMML is transforming into an acute leukemia.
For bone marrow aspiration, you lie flat on a table (either on your side or on your belly). After cleaning the skin over the hip, the surface of the bone is numbed with local anesthetic. A very thin needle is used to put in the numbing drug, which may cause a brief stinging or burning sensation. A long, hollow needle is then put into the bone and a syringe is used to suck out a small amount of liquid bone marrow (about 1 teaspoon). Even with the anesthetic, most patients still have some brief pain when the marrow is removed.
A bone marrow biopsy is usually done right after the aspiration. A small core of bone and marrow (about 1/16 inch in diameter and 1/2 inch long) is removed with a wider needle that's twisted as it's pushed into the hip bone. The biopsy may also cause some brief pain. Once the biopsy is done, pressure will be held to help prevent bleeding and bruising.
A pathologist(a doctor specializing in the diagnosis of diseases using laboratory tests) examines the bone marrow samples under a microscope. A hematologist(a doctor specializing in medical treatment of diseases of the blood and blood-forming tissues) or an oncologist(a doctor specializing in medical treatment of cancer) usually looks at the samples too.
Looking at the cells in the bone marrow
The doctors will look at the types and number of blood-forming cells in the bone marrow aspirate and biopsy. They will also check to see if the bone marrow shows signs of infections, cancer cells, or other disorders. They will examine the size and shape of the cells and determine whether the red cells contain iron particles or the other cells contain granules (microscopic collections of enzymes and other chemicals that help white blood cells to fight infections).
Measuring blasts
Tests will be done to measure the percentage of marrow cells that are blasts. This is very important. Blasts are very early (immature) cells that are madeby bone marrow stem cells. Over time, blasts mature into normal blood cells. But in CMML, some of the blasts do not mature properly, so there may be too many blasts and not enough mature cells. For a diagnosis of CMML, there must be less than 20% blasts in the bone marrow. A patient who has more than 20% blasts in the bone marrow has acute leukemia 2 .
Cytogenetic tests
This test looks at the chromosomes inside the cells. DNA in human cells is packed into chromosomes. Each cell should have 46 chromosomes (23 pairs). Chromosome changes or abnormalities are fairly common in CMML. Sometimes pieces of chromosomes or even whole chromosomes are missing. CMML cells may also have extra copies of all or part of some chromosomes. Chromosome translocations may also be seen. This is where parts of chromosomes trade places with each other.
Chromosome testing can also help the doctors be sure that the problem isn't a different leukemia, called chronic myeloid leukemia or CML 3 . The leukemia cells in CML often contain an abnormal chromosome caused by a certain translocation. This is called the Philadelphia chromosome or BCR/ABL fusion. If the Philadelphia chromosome is present, the diagnosis is CML, not CMML. CMML also does not have changes in certain genes, called PDGFRA and PDGFRB. If these changes are present the problem might be a different myeloproliferative disorder.
Cytogenetic testing can take several weeks because the bone marrow cells need time to grow in laboratory dishes before the chromosomes can be seen with a microscope. The results of cytogenetic testing are written in a way that describes which chromosome changes are present. For instance:
A minus sign (-) or the abbreviation "del" is used to mean a deletion. So, if a copy of chromosome 7 is missing, it can be written as -7 or del (7) . Often, only a part of the chromosome is lost. There are 2 parts to a chromosome, called p and q. So the loss of the q part of chromosome 20 is called 20q-or del(20q). The letter "t" is used to indicate a translocation, which is when a piece of one chromosome breaks off and becomes part of another chromosome. 
Survival Rates for Chronic Myelomonocytic Leukemia
There is more than one way to describe a person's likely prognosis (outlook). The statistics below talk about median survival. Median survival is the amount of time for half the patients in a group to die. This is a middle value --half the patients live longer than this, and half do not live this long.
In order to get median survival estimates, doctors have to look at people who were treated several years ago. Improvements in treatment since then may result in a more favorable outlook for people now being diagnosed with chronic myelomonocytic leukemia (CMML).
Median survival estimates are based on previous outcomes of large numbers of people who had the disease, but they cannot predict what will happen in any particular person's case. Many other factors may affect a person's outlook, such as their age and overall health. Your doctor can tell you how the numbers below may apply to you, as he or she is familiar with the aspects of your particular situation.
Patients with CMML-1 tend to live longer than those with CMML-2. In one study of CMML patients diagnosed between 1975 and 2005, the median survival times with CMML-1 and CMML-2 were 20 months and 15 months, respectively. However, some patients lived much longer. About 20% of CMML-1 patients and about 10% of CMML-2 patients survived longer than 5 years. Also, patients with CMML-2 are more likely to go on to develop acute leukemia than patients with CMML-1. In the same study, 18% of CMML-1 patients and 63% of CMML-2 patients developed acute myeloid leukemia within 5 years of their CMML diagnosis.
In addition to the type of CMML, other factors may be helpful in predicting survival. These include blood cell counts, certain chromosome changes, and blood levels of LDH (lactate dehydrogenase).
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How is CMML treated?
Treatment for CMML may include: 
Common treatment approaches
Treatment of CMML is based on how severe the disease is, as well as your age and overall health. For many people with CMML, supportive therapy to prevent the problems caused by low blood cell counts is an important part of treatment. 
General Approach to Treatment of Chronic Myelomonocytic Leukemia
Making treatment decisions
It's important to discuss all treatment options, including their goals and possible side effects, with your doctors to help make the decision that best fits your needs. You may feel that you need to make a decision quickly, but it's important to give yourself time to absorb the information you have learned. Ask your cancer care team questions.
If time permits, it is often a good idea to seek a second opinion. A second opinion can give you more information and help you feel more confident about the treatment plan you choose. 
Questions to Ask Your Doctor About Chronic Myelomonocytic Leukemia
Thinking about taking part in a clinical trial
Clinical trials are carefully controlled research studies that are done to get a closer look at promising new treatments or procedures. Clinical trials are one way to get state-ofthe art cancer treatment. In some cases they may be the only way to get access to newer treatments. They are also the best way for doctors to learn better methods to treat cancer. Still, they're not right for everyone.
If you would like to learn more about clinical trials that might be right for you, start by asking your doctor if your clinic or hospital conducts clinical trials. 
Considering complementary and alternative methods
You may hear about alternative or complementary methods that your doctor hasn't mentioned to treat your cancer or relieve symptoms. These methods can include vitamins, herbs, and special diets, or other methods such as acupuncture or massage, to name a few.
Complementary methods refer to treatments that are used along with your regular medical care. Alternative treatments are used instead of a doctor's medical treatment. Although some of these methods might be helpful in relieving symptoms or helping you feel better, many have not been proven to work. Some might even be harmful.
Be sure to talk to your cancer care team about any method you are thinking about using. They can help you learn what is known (or not known) about the method, which can help you make an informed decision.
Complementary and Alternative Medicine 5 q
Help getting through cancer treatment
Your cancer care team will be your first source of information and support, but there are other resources for help when you need it. Hospital-or clinic-based support services are an important part of your care. These might include nursing or social work services, financial aid, nutritional advice, rehab, or spiritual help.
The American Cancer Society also has programs and services -including rides to treatment, lodging, and more -to help you get through treatment. Call our National Cancer Information Center at 1-800-227-2345 and speak with one of our trained specialists. 
Find Support Programs and Services in Your Area
Choosing to stop treatment or choosing no treatment at all
For some people, when treatments have been tried and are no longer controlling the cancer, it could be time to weigh the benefits and risks of continuing to try new treatments. Whether or not you continue treatment, there are still things you can do to help maintain or improve your quality of life. Some people, especially if the cancer is advanced, might not want to be treated at all. There are many reasons you might decide not to get cancer treatment, but it's important to talk to your doctors and you make that decision. Remember that even if you choose not to treat the cancer, you can still get supportive care to help with pain or other symptoms. 
If
Supportive Therapy for the Patient With Chronic Myelomonocytic Leukemia
Chronic myelomonocytic leukemia (CMML) can be hard to treat. For many people with CMML, the main goal is to prevent the problems caused by low blood cell counts. For instance, low red blood cell counts 1 (anemia) can cause severe fatigue. Treating the anemia with blood transfusions 2 and/or erythropoietin can help patients feel better and allow them to be more active.
Some people are concerned about a slight risk of infection (hepatitis or HIV) spread by blood transfusion. This possibility is very unlikely, and the benefits of the transfused cells greatly outweigh this risk.
People with CMML often need a lot of blood transfusions. This can cause excess iron to build up in the body. This extra iron can deposit in the liver and heart, affecting how well the organs work. This iron build up is usually seen only in people who receive many transfusions over a period of years. Drugs called chelating agents can be used to treat and prevent iron overload from transfusions. Chelating agents are substances that bind with iron so that the body can get rid of it. They can be given intravenously (IV) or as an injection (shot) under the skin.
American Cancer Society cancer.org | 1.800.227.2345 ____________________________________________________________________________________ CMML patients with bleeding problems caused by a shortage of platelets may benefit from platelet transfusions.
People with CMML tend to get infections very easily. They should be especially careful to avoid cuts and scrapes and care for any injury right away. They should tell their doctors about any fever, signs of pneumonia (cough, shortness of breath), urinary infection (burning when urinating), or other signs of infection right away. Doctors will treat any known or suspected infections with antibiotics. See Infections in People with Cancer 3 for more details.
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Chemotherapy (chemo) is the use of drugs for treating a disease such as cancer. The drugs can be swallowed as pills, or a needle can be used to inject them into a vein or muscle. Chemo is considered systemic treatment because these drugs enter the bloodstream and reach most areas of the body. This type of treatment is useful for diseases like chronic myelomonocytic leukemia (CMML) that are not only in one part of the body. Chemo cannot cure CMML, but it can help kill the abnormal bone marrow cells and allow normal ones to grow back.
Hydroxyurea
Hydroxyurea (hydroxycarbamate, Hydrea ® ) is a chemo drug that has helped some patients with CMML live longer. This drug comes as a capsule that's taken by mouth daily. It can bring the numbers of white blood cells and monocytes down to normal. It may also help shrink an enlarged spleen. Because the main effect of hydroxyurea is to lower blood counts, anyone taking this drug will have their blood counts checked regularly. Other side effects are usually mild and easily tolerated. Some patients have stayed on this drug for years without problems.
Hypomethylating agents
These drugs are affect the way genes are controlled. Examples of this type of drug include azacytidine (Vidaza ® ) and decitabine (Dacogen ® ). Azacytidine is given as a shot under the skin or into your blood (IV) for 7 days in a row every month. Decitabine is given into your blood (IV), either once every 8 hours for 3 days, or once a day for 5 days. These drugs have been studied best in treating myelodysplastic syndromes 1 , where they seem to help stop abnormal cells in the bone marrow from dividing to make new cells. This lets the normal cells grow again, often leading to improved blood counts and less need for transfusions. Fewer patients with CMML have been treated with these drugs in studies, but they had similar benefits in terms of blood counts.
Side effects are usually mild and rarely lead to stopping treatment. Still, these drugs can have some of the same side effects as regular chemotherapy, including: Nausea/vomiting 
Conventional chemotherapy
For a long time, CMML was grouped with myelodysplastic syndromes 2 , and so it was treated with the same chemo drugs. Some of the chemo combos that have been used include:
Cytarabine (ara-C) with idarubicin This type of treatment can help some patients, but it can cause severe side effects, including life-threatening infections ror other problems. Using lower doses of chemo drugs.is an appoach that can help lower the chance of serious side effects. This treatment is generally only used in young and otherwise healthy people with CMML. Most patients with CMML are older and have other health problems. They are less likely to benefit from this intense type of chemo. Still, this may be an option for some people with advanced CMML.
Chemo drugs can cause many side effects 3 . The side effects depend on the type and dose of the drugs that are given and the how long they are taken. 
Growth Factors for Treating Chronic Myelomonocytic Leukemia
Hematopoietic growth factors are hormone-like substances that stimulate bone marrow to produce blood cells. These substances occur naturally in the body, but scientists have found a way to make them in large amounts. This lets patients get larger doses of these growth factors than their body would make. Growth factor drugs are usually given by subcutaneous (under the skin) injections (shots).
Shortages of blood cells cause many of the symptoms in people with chronic myelomonocytic leukemia (CMML), and growth factors can help keep blood counts at more normal levels.
Erythropoietin (Epo ® or Procrit ® ) is a growth factor that promotes red blood cell production. It can help some patients avoid getting a lot of red blood cell transfusions. Sometimes erythropoietin is given along with a growth factor for white blood cells (G-CSF, Neupogen ® , or filgrastim) to improve the patient's response to the erythropoietin.
Darbepoetin (Aranesp ® ) is a long-acting form of erythropoietin. It works in the same way but can be given less often.
A drug called oprelvekin (Neumega ® , interleukin-11, or IL-11) can be used to stimulate platelet production. This drug can help increase the platelet counts of some CMML patients for a time, but then the counts go down again. For most people with CMML, this drug is not very helpful.
Stem Cell Transplant for Chronic Myelomonocytic Leukemia
Stem cell transplant (SCT) is the only treatment that can cure chronic myelomonocytic leukemia (CMML). In this treatment, the patient gets high-dose chemotherapy often along with radiation to the entire body to kill the cells in the bone marrow (including the abnormal bone marrow cells). Then the patient is given new, healthy blood-forming stem cells. The 2 main types of SCT are: allogeneic and autologous.
In an autologous stem cell transplant, after the bone marrow is destroyed, the patient gets back their own stem cells. This type of transplant is not a standard treatment for patients with CMML because their bone marrow has abnormal stem cells.
For an allogeneic stem cell transplant, the patient gets blood-forming stem cells from another person --the donor. The best results are when the donor's cells are closely matched to the patient's cell type and the donor is closely related to the patient, such as a brother or sister. Less often, an unrelated donor is matched to the patient.
Allogeneic stem cell transplant can have serious, even fatal, side effects and so is rarely used in elderly patients. Because of these side effects, some doctors only use this treatment for people younger than a certain age.
A special type of allogeneic transplant, a non-myeloablative allogeneic stem cell transplant, may be an option for older patients. This type of transplant is sometimes called a mini-transplant or a mini-allo. In this type, the doses of chemo and/or radiation that are given are lower than those used for a standard allogeneic transplant. These doses are not high enough to kill all the bone marrow cells, but they kill just enough to allow the donor cells to take hold and grow in the bone marrow. The lower doses of chemo and/or radiation cause fewer side effects, which makes this type of transplant easier for older patients to tolerate. Still, it has some serious side effects.
For now, allogeneic SCT is the only treatment that can cure some patients with CMML, but not all patients who get a transplant are cured. And patients can die from complications of this treatment. Also, many people with CMML are not able to get this treatment.
For more information, see Stem Cell Transplant for Cancer 1 .
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General Approach to Treatment of Chronic Myelomonocytic Leukemia
Stem cell transplant (SCT) is the only way to cure patients with chronic myelomonocytic leukemia (CMML). It may be the treatment of choice for younger patients when a matched donor is available. Advances in SCT processes mean this treatment could also be an option for some older patients.
If SCT is not an option, CMML is not curable. In this case, the goal is to relieve symptoms while limiting complications and reducing side effects 1 . Supportive care, such as transfusions, blood cell growth factors, and antibiotics to treat infections, is used to treat all patients with CMML so they can live as long as possible.
Many times no treatment is needed for CMML but if it is, either the drug azacytidine
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American Cancer Society cancer.org | 1.800.227.2345 ____________________________________________________________________________________ (Vidaza) or decitabine (Dacogen) is often the first choice. These drugs may make blood counts drop for a time after treatment is started. Then, if the drug is working, blood counts rise to levels above those seen before treatment was started.
A major benefit for patients receiving azacytidine or decitabine is less need for transfusions and an improved quality of life. If their disease responds, the patients often are less fatigued and are able to function more normally.
Treatment with hydroxyurea can help some patients who have high white blood cell counts. This drug can help lower monocyte counts and decrease the need for transfusions. It can also shrink the spleen to help the patient feel more comfortable.
Conventional chemotherapy using drug combinations used to treat acute myeloid leukemia 2 can be an option for patients who are younger and otherwise healthy, but it's rarely used.
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Living as a Chronic Myelomonocytic Leukemia Survivor
Since chronic myelomonocytic leukemia (CMML) is rarely cured, most patients never actually complete treatment. Patients may go through a series of treatments with rests in-between. Some people stop active treatment in favor of supportive care
1 . Learning to live with cancer that does not go away can be difficult and very stressful. See Managing Cancer As A Chronic Illness 2 for more about this.
Follow-up care
Even if you have stopped your treatment for CMML, it is still very important to go to all your follow-up appointments. During these visits, your doctors will ask about symptoms, physically examine you, and order blood tests. They will continue to watch for signs of infection 3 and signs that you are moving on to active leukemia 4 . They'll also watch for short-term and long-term side effects 5 of treatment. This is the time for you to ask your health care team any questions and to discuss any concerns you might have.
Almost any cancer treatment can have side effects. Some might last for just a few weeks or months, but others can be permanent. Don't hesitate to tell your cancer care team about any symptoms or side effects that bother you so they can help you manage them.
Ask your doctor for a survivorship care plan
Your survivorship care plan might include:
A suggested schedule for follow-up exams and tests q A schedule for other tests you might need in the future, such as early detection (screening) tests for other types of cancer, or tests to look for long-term health effects from your cancer or its treatment 
Keeping health insurance and copies of your medical records
Even after treatment, it's very important to keep your health insurance. With a chronic disease like CMML, your treatment may never really be over. Tests and doctor visits cost a lot, and even though no one wants to think about their cancer coming back or having to continue treatment for a long time, this could happen.
At some point after your cancer treatment, you might find yourself seeing a new doctor who doesn't know about your medical history. It's important to keep copies of your medical records to give your new doctor the details of your diagnosis and treatment. Learn more in Keeping Copies of Important Medical Records 6 .
Can I lower my risk of CMML progressing or coming back?
If you have (or have had) CMML, you probably want to know if there are things you can do that might lower your risk of the cancer growing or coming back, such as exercising,
